Author:
Lu Jian-Feng,Fan Ze-Xin,Li Ying,Wang Ze-Yi,Ma Lin,Yuan Bo-Yi,Yang Ting-Ting,Liu Pen-Ju,Liu Guang-Zhi
Abstract
ObjectiveThis study aimed to explore risk factors, clinical features, and prognosis of patients with hypertrophic cardiomyopathy (HCM) complicated by ischemic stroke (IS).MethodsWe conducted a retrospective analysis of all HCM patient data and a 1-year follow-up study.ResultsTotally, 506 patients with HCM, including 71 with IS, were enrolled. Older age (≥63 years) was associated with an increased risk of IS in HCM patients (OR = 1.045, 95% CI: 1.018–1.072, p = 0.001). Among 37 patients complicated by IS, 22 (59.5%, 22/37) manifested as cardioembolism (CE) subtype, and 13 (35.1%, 3/37) small artery occlusion (SAO) subtype, according to TOAST classification. In the acute phase, the IS patients presented with NIHSS 4 (interquartile range: 1, 10). Multi-infarction was more common than single infarction (72.7 vs. 27.3%), while cortical + subcortical infarction (CE group: 50%) or subcortical infarction (SAO group: 53.8%) constituted most IS cases. Additionally, the blood supply areas of anterior circulation (CE group: 45.5%; SAO group: 92.3%) or anterior + posterior circulation (CE group: 50%) were mainly involved. The 1-year survival rate of HCM patients with concomitant IS was 81.8%, and IS was associated with 1-year all-cause death in HCM patients (HR = 5.689, 95% CI: 1.784–18.144, p = 0.003).ConclusionOlder age is a risk factor for IS occurrence in HCM patients. Patients with HCM complicated by IS had mild or moderate neurologic deficits at disease onset. CE and SAO subtypes predominate in patients with concomitant IS, especially the former. Multiple cortical and subcortical infarctions are their neuroimaging characteristics, mainly involving the anterior circulation or anterior + posterior circulation. Is is a risk factor for all-cause death in HCM patients within 1 year.
Subject
Cardiology and Cardiovascular Medicine
Reference39 articles.
1. Management of hypertrophic cardiomyopathy: JACC state-of-the-art review;Maron;J Am Coll Cardiol.,2022
2. Hypertrophic cardiomyopathy: the future of treatment;Tuohy;Eur J Heart Fail.,2020
3. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy;Marian;Circ Res.,2017
4. Thromboembolism in patients with hypertrophic cardiomyopathy;Liu;Int J Med Sci.,2021
5. Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology;Mizia-Stec;ESC Heart Fail.,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献